On ECHEMI
Home > Drugs > Henan Runhong Pharmaceutical Co., Ltd.

Henan Runhong Pharmaceutical Co., Ltd.

  • Founded in:

    2002-06-26
  • Country:

    China China
  • Address:

    No. 227, Qing'an Road, Xinzheng City
  • Tax NO.:

    914101007407005718
  • Registered Funds:

    340.484 million yuan
  • Website:

  • Email:

Related Drugs
Bupleurum injection
Bupleurum
Name Description Content CAS NO. Registered Holders
Bupleurum

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

0
Paracetamol injection
A combination preparation consisting of acetaminophen and antipyrine.
Name Description Content CAS NO. Registered Holders
Acetaminophen

It takes a long time to take effect, but lasts for a long time, up to 6-8 hours, and has antipyretic and analgesic effects.

More

It takes a long time to take effect, but lasts for a long time, up to 6-8 hours, and has antipyretic and analgesic effects.

103-90-2 68
Antipyrine

The antipyretic and analgesic effects take effect quickly and have strong analgesic efficacy, ensuring that the antipyretic and analgesic effects are produced within 15-20 minutes.

More

The antipyretic and analgesic effects take effect quickly and have strong analgesic efficacy, ensuring that the antipyretic and analgesic effects are produced within 15-20 minutes.

60-80-0 9
Aminophylline Injection
Aminophylline
Name Description Content CAS NO. Registered Holders
Aminophylline

It has a direct relaxant effect on the smooth muscles of the respiratory tract; it partly increases the intracellular cAMP content by inhibiting phosphodiesterase; it partly produces a bronchodilator effect by releasing endogenous adrenaline and norepinephrine; as a purine receptor blocker, it can counteract the contractile effect of adenine and other substances on the respiratory tract; it enhances the contractility of the diaphragm and improves respiratory function; it has a weak effect of relaxing the smooth muscles of the coronary arteries, peripheral blood vessels and bile ducts; it slightly increases the contractility of the heart and has a diuretic effect.

More

It has a direct relaxant effect on the smooth muscles of the respiratory tract; it partly increases the intracellular cAMP content by inhibiting phosphodiesterase; it partly produces a bronchodilator effect by releasing endogenous adrenaline and norepinephrine; as a purine receptor blocker, it can counteract the contractile effect of adenine and other substances on the respiratory tract; it enhances the contractility of the diaphragm and improves respiratory function; it has a weak effect of relaxing the smooth muscles of the coronary arteries, peripheral blood vessels and bile ducts; it slightly increases the contractility of the heart and has a diuretic effect.

317-34-0 10
Vinpocetine Injection
The main ingredient of this product is vinpocetine. The auxiliary materials are: vitamin C, sodium metabisulfite, tartaric acid, sorbitol, benzyl alcohol, and water for injection.
Name Description Content CAS NO. Registered Holders
Vinpocetine

It has neuroprotective effects, promotes brain metabolism, improves brain microcirculation, and selectively increases brain blood flow. Specifically, it relieves the cytotoxic effects induced by excitatory amino acids, inhibits sodium and calcium channels, NMDA and AMPA receptors, and enhances the neuroprotective effects of adenosine; increases the intake and consumption of glucose and oxygen by brain tissue, improves brain hypoxia tolerance, increases ATP concentration and ATP/AMP ratio, promotes the renewal of norepinephrine and 5-hydroxytryptamine, and has an antioxidant effect; inhibits platelet aggregation, reduces pathological blood viscosity, increases red blood cell deformability, and promotes oxygen transport in tissues; increases the percentage of cardiac output supplied to the brain, reduces cerebrovascular resistance without affecting systemic circulation parameters, and promotes blood supply to low-perfusion ischemic areas.

More

It has neuroprotective effects, promotes brain metabolism, improves brain microcirculation, and selectively increases brain blood flow. Specifically, it relieves the cytotoxic effects induced by excitatory amino acids, inhibits sodium and calcium channels, NMDA and AMPA receptors, and enhances the neuroprotective effects of adenosine; increases the intake and consumption of glucose and oxygen by brain tissue, improves brain hypoxia tolerance, increases ATP concentration and ATP/AMP ratio, promotes the renewal of norepinephrine and 5-hydroxytryptamine, and has an antioxidant effect; inhibits platelet aggregation, reduces pathological blood viscosity, increases red blood cell deformability, and promotes oxygen transport in tissues; increases the percentage of cardiac output supplied to the brain, reduces cerebrovascular resistance without affecting systemic circulation parameters, and promotes blood supply to low-perfusion ischemic areas.

42971-09-5 17
Vinpocetine Injection
The main ingredient of this product is vinpocetine. The auxiliary materials are: vitamin C, sodium metabisulfite, tartaric acid, sorbitol, benzyl alcohol, and water for injection.
Name Description Content CAS NO. Registered Holders
Vinpocetine

1. Neuroprotective effect: relieves the cytotoxic effect induced by excitatory amino acids, inhibits voltage-dependent sodium and calcium channels, NMDA and AMPA receptors, and enhances the neuroprotective effect of adenosine; 2. Promotes brain metabolism: increases the intake and consumption of glucose and oxygen by brain tissue, improves the brain's tolerance to hypoxia, enhances the transport of glucose across the blood-brain barrier, selectively inhibits calcium calmodulin-dependent cGMP-phosphodiesterase, increases cGMP and cAMP levels in the brain, increases ATP concentration and ATP/AMP ratio, promotes the renewal of norepinephrine and 5-hydroxytryptamine, and has an antioxidant effect; 3. Improves brain microcirculation: inhibits platelet aggregation, reduces pathological blood viscosity, increases red blood cell deformability, inhibits red blood cell uptake of adenosine, and promotes tissue oxygen transport by reducing red blood cell oxygen affinity; 4. Selectively increases cerebral blood flow: increases the percentage of cardiac output supplied to the brain, reduces cerebrovascular resistance without affecting systemic circulation parameters, and promotes blood supply to damaged hypoperfused ischemic areas.

More

1. Neuroprotective effect: relieves the cytotoxic effect induced by excitatory amino acids, inhibits voltage-dependent sodium and calcium channels, NMDA and AMPA receptors, and enhances the neuroprotective effect of adenosine; 2. Promotes brain metabolism: increases the intake and consumption of glucose and oxygen by brain tissue, improves the brain's tolerance to hypoxia, enhances the transport of glucose across the blood-brain barrier, selectively inhibits calcium calmodulin-dependent cGMP-phosphodiesterase, increases cGMP and cAMP levels in the brain, increases ATP concentration and ATP/AMP ratio, promotes the renewal of norepinephrine and 5-hydroxytryptamine, and has an antioxidant effect; 3. Improves brain microcirculation: inhibits platelet aggregation, reduces pathological blood viscosity, increases red blood cell deformability, inhibits red blood cell uptake of adenosine, and promotes tissue oxygen transport by reducing red blood cell oxygen affinity; 4. Selectively increases cerebral blood flow: increases the percentage of cardiac output supplied to the brain, reduces cerebrovascular resistance without affecting systemic circulation parameters, and promotes blood supply to damaged hypoperfused ischemic areas.

42971-09-5 17
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.